Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol MR vs Metoprolol XL in Hypertension with Microalbuminuria
NCT00123903Phase 3Terminated
- Sponsor
- GSK
- Start
- Jul 2005
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of carvedilol phosphate in hypertension (HTN) and Microalbuminuria (2 arms), sponsored by GSK. Primary endpoint: Change from baseline in urine albumin: creatinine ratio (ACR) at 6 months. Started Jul 2005; status: terminated.
02
Drugs
carvedilol phosphate
03
Conditions
hypertension (HTN)Microalbuminuria
Beyond the preview
Go deeper on NCT00123903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123903.